Page 76 - 南京医科大学学报自然科学版
P. 76

第44卷第3期
               ·366 ·                          南   京 医 科       大 学      学 报                        2024年3月


                   Barré and Miller Fisher syndromes⁃new diagnostic classi⁃  and gangliosides in Hashimoto’s thyroiditis compared to
                   fication[J]. Nat Rev Neurol,2014,10(9):537-544    other thyroid illnesses[J]. Psychoneuroendocrinology,
             [10] FEHMI J,SCHERER S S,WILLISON H J,et al. Nodes,     2009,34(8):1252-1256
                   paranodes and neuropathies[J]. J Neurol Neurosurg Psy⁃  [20] MORAN A P,ANNUK H,PRENDERGAST M M. Anti⁃
                   chiatry,2018,89(1):61-71                          bodies induced by ganglioside⁃mimicking Campylobacter
             [11] DOPPLER K,APPELTSHAUSER L,VILLMANN C,et            jejuni lipooligosaccharides recognise epitopes at the
                   al. Auto ⁃ antibodies to contactin ⁃ associated protein 1  nodes of Ranvier[J]. J Neuroimmunol,2005,165(1/2):
                  (Caspr)in two patients with painful inflammatory neurop⁃  179-185
                   athy[J]. Brain,2016,139(Pt 10):2617-2630     [21] YUKI N,YAMADA M,KOGA M,et al. Animal model of
             [12] SHAHRIZAILA N,LEHMANN H C,KUWABARA S.              axonal Guillain⁃Barré syndrome induced by sensitization
                   Guillain⁃Barré syndrome[J].Lancet,2021,397(10280):  with GM1 ganglioside[J]. Ann Neurol,2001,49(6):

                   1214-1228                                         712-720
             [13] AL OTHMAN B,RAABE J,KINI A,et al. Update:the  [22] YUKI N,SUSUKI K,KOGA M,et al. Carbohydrate mim⁃
                   Miller Fisher variants of Guillain ⁃ Barré syndrome[J].  icry between human ganglioside GM1 and Campylobacter
                   Curr Opin Ophthalmol,2019,30(6):462-466           jejuni lipooligosaccharide causes Guillain⁃Barre syndrome
             [14] RAGUSA F,FALLAHI P,ELIA G,et al. Hashimotos’thy⁃  [J]. Proc Natl Acad Sci USA,2004,101(31):11404-
                   roiditis:Epidemiology,pathogenesis,clinic and therapy  11409
                  [J]. Best Pract Res Clin Endocrinol Metab,2019,33(6):  [23] MULLIN B R,PACUSZKA T,LEE G,et al. Thyroid gan⁃
                   101367                                            gliosides with high affinity for thyrotropin:potential role
             [15] ALI A,MALIK W T,RAJA U,et al. Thyroid storm,a mim⁃  in thyroid regulation[J]. Science,1978,199(4324):77-
                   icker of guillain⁃barre syndrome:a case report[J]. Cure⁃  79
                   us,2020,12(8):e9918                          [24] LARDONE R D,YUKI N,ODAKA M,et al. Anti⁃GM1
             [16] TOUDOU DAOUDA M,OBENDA N S,MAAZOU L,et             IgG antibodies in Guillain⁃Barré syndrome:fine specificity
                   al. Guillain⁃Barre syndrome and Hashimoto’s thyroiditis  is associated with disease severity[J]. J Neurol Neuro⁃
                  [J]. QJM,2016,109(8):547-548                       surg Psychiatry,2010,81(6):629-633
             [17] KOHLI R S,BLEIBEL W,BLEIBEL H. Concurrent im⁃  [25] SUSUKI K,RASBAND M N,TOHYAMA K,et al. Anti⁃
                   mune thrombocytopenic purpura and Guillain⁃Barre syn⁃  GM1 antibodies cause complement ⁃ mediated disruption
                   drome in a patient with Hashimoto’s thyroiditis[J]. Am J  of sodium channel clusters in peripheral motor nerve fibers
                   Hematol,2007,82(4):307-308                       [J]. J Neurosci,2007,27(15):3956-3967
             [18] ZANG Q L,WANG Y T,GUO J S,et al. Treatment of se⁃  [26] THOMMA R C M,FOKKE C,WALGAARD C,et al. High
                   vere Japanese encephalitis complicated with hashimoto’s  and persistent anti ⁃ GM1 antibody titers are associated
                   thyroiditis and guillain⁃barré syndrome with protein A im⁃  with poor clinical recovery in guillain⁃barré syndrome[J].
                   munoadsorption:a case report[J]. Front Immunol,2022,  Neurol Neuroimmunol Neuroinflamm,2023,10(4):
                   12:807937                                         e200107
             [19] MÜSSIG K,LEYHE T,HOLZMÜLLER S,et al. Increased                          [收稿日期] 2023-11-01
                   prevalence of antibodies to central nervous system tissue                   (本文编辑:戴王娟)
   71   72   73   74   75   76   77   78   79   80   81